| Trial ID: | L1927 |
| Source ID: | NCT02125682
|
| Associated Drug: |
Atovastatin 10 Mg/Day
|
| Title: |
The HDL Particle Protection Study
|
| Acronym: |
HDL PROTECT
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Dyslipidemia in Patients With Diabetes Mellitus
|
| Interventions: |
DRUG: atovastatin 10 mg/day|DRUG: Atorvastatin 80 mg/day
|
| Outcome Measures: |
Primary: effect on HDL function, Does atorvastatin 80 mg/day improve HDL function more than 10 mg/day. HDL function will be assessed via several tests, 8 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Hotel Dieu de France Hospital | Collaborators: Nouvelle Société Française d'Athérosclérose|Pfizer
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2012-01
|
| Completion Date: |
2017-05-14
|
| Results First Posted: |
|
| Last Update Posted: |
2018-02-01
|
| Locations: |
Hotel Dieu de France Hospital, Beirut, Beirut, Lebanon
|
| URL: |
https://clinicaltrials.gov/show/NCT02125682
|
